FDA Drug Recalls

Recalls / Class III

Class IIID-0599-2021

Product

Atorvastatin Calcium Tablets, USP 10 mg*, Rx Only, 500 count bottle, Mfd By: Dr. Reddy's Laboratories Limited, Bachupally 500 090, India, NDC 55111-121-05.

Brand name
Atorvastatin Calcium
Generic name
Atorvastatin Calcium
Active ingredient
Atorvastatin Calcium Trihydrate
Route
Oral
NDCs
55111-121, 55111-122, 55111-123
FDA application
ANDA091650
Affected lot / code info
Lot # C905063, Exp 07/2021

Why it was recalled

Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

Recalling firm

Firm
Dr. Reddy's Laboratories, Inc.
Manufacturer
Dr. Reddy's Laboratories Limited
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
107 College Rd E, N/A, Princeton, New Jersey 08540-6623

Distribution

Quantity
2980 500 count -bottles
Distribution pattern
Distributed Nationwide in the USA

Timeline

Recall initiated
2021-05-04
FDA classified
2021-05-27
Posted by FDA
2021-06-02
Terminated
2023-02-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0599-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Atorvastatin Calcium · FDA Drug Recalls